|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.59 USD | -0.60% |
|
+2.24% | -17.79% |
| Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
| Apr. 10 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
Ionis Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 788 million compared to USD 587 million a year ago. Net loss was USD 366 million compared to USD 270 million a year ago.
Basic loss per share from continuing operations was USD 2.56 compared to USD 1.9 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.79% | 6.07B | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
IONIS PHARMACEUTICALS, INC. 
